Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma

doi:10.5306/wjco.v15.i1.62

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1822)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-15) series.

Item

Count

PDF

WORD

HTML

886

Figures (1-15)

118

Sum=1053

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

180

Sum=257

Publishing Process of This Article

Item

Count

Browse

121

Download

342

Sum=463

Jan 24, 2024 (publication date) through Jul 19, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Oncol. Jan 24, 2024; 15(1): 62-88
Published online Jan 24, 2024. doi: 10.5306/wjco.v15.i1.62

Full Size Figure Download Figure

Figure 2 Flow chart showing the collection of the transcatheter arterial embolisation-treated hepatocellular carcinoma samples. Finally, one study was included. HCC: Hepatocellular carcinoma; TACE: Transcatheter arterial chemoembolization.

Citation: Huang JZ, Li JD, Chen G, He RQ. Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma. World J Clin Oncol 2024; 15(1): 62-88
URL: https://www.wjgnet.com/2218-4333/full/v15/i1/62.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i1.62